Afluria

BIOLOGICAL3 trials

Sponsors

University of Massachusetts, Worcester, Protein Sciences Corporation, National Heart, Lung, and Blood Institute (NHLBI)

Conditions

Immune ResponseInfluenzaLymphoma

Phase 3

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

CompletedNCT01825200

Protein Sciences CorporationInfluenza

Start: 2013-03-31End: 2013-05-31Updated: 2015-02-18

Phase 4

Vaccine Responses in Patients With B Cell Malignancies

RecruitingNCT05170399

National Heart, Lung, and Blood Institute (NHLBI)Lymphoma

Start: 2022-09-14End: 2026-08-16Target: 500Updated: 2026-02-05

Unknown Phase

Immune Responses Induced by Different Licensed Influenza Vaccines

CompletedNCT00902278

University of Massachusetts, WorcesterImmune Response

Start: 2008-10-31End: 2016-04-30Updated: 2017-11-20

Related Papers

Randomized comparison of the safety of Flublok(®) versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥ 50 years of age.

2015-11-0121 citations